Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin for Dyslipidemia in HIV Patients on Atazanavir/Ritonavir
NCT02442700Phase 4Completed
- Sponsor
- Ramathibodi Hospital
- Start
- May 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of pitavastatin in dyslipidemia (2 arms), sponsored by Ramathibodi Hospital. Primary endpoint: Lipid Profile (TC, TG, LDL, HDL) at 12 weeks. Started May 2014; status: completed.
02
Drugs
pitavastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02442700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442700.